Clinical Trial Update: Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of a raltegravir-based regimen on platelet reactivity, platelet-monocyte aggregation, and immune activation in HIV patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• raltegravir-based regimen (raltegravir)

Snippet

Sponsor: Radboud University Medical Center | Conditions: HIV | Phase 4 | Status: COMPLETED | Results posted: 2019-01-10